HopeStage
Back to all studies
CompletedNCT00632229

Paliperidone or placebo added to ongoing treatment for persistent OCD symptoms

About this titleRead the official source — NCT00632229

Researchers compared Paliperidone and placebo to find out how the approaches affected obsessive thoughts and compulsive behaviours in people with OCD.

Medication studyAges 18–70United States
The study in practice

Understand this study

What did researchers investigate?

Researchers compared Paliperidone and placebo to find out how the approaches affected obsessive thoughts and compulsive behaviours in people with OCD.

Who was this study for?

Listed age limits: 18 years to 70 years.

Listed locations
St. Petersburg and 1 more locationSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateOctober 2007
Recruitment status
Completed
Enrollment listed in the registry
34
Sponsor
University of South Florida
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT00632229
Official title
Show the full official title

Double Blinded, Placebo-Controlled Trial of Paliperidone Addition in SRI-Resistant Obsessive-Compulsive Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

St. Petersburg · Indianapolis

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers compared Paliperidone and placebo to find out how the approaches affected obsessive thoughts and compulsive behaviours in people with OCD.

Who is behind this study?

The study sponsor is University of South Florida, a university.

Did this study involve medication?

Yes. The study involved medication, including Paliperidone and Placebo.

Who was this study for?

Listed age limits: 18 years to 70 years.

Want to explore more studies?

Explore studies